Publication | Closed Access

Population pharmacokinetic–pharmacodynamic target attainment analysis of sulbactam in patients with impaired renal function: Dosing considerations for Acinetobacter baumannii infections

Acinetobacter Baumannii InfectionsAntimicrobial SusceptibilityPharmacokinetic ModelingAntibioticsPharmacologyAntimicrobial ResistanceAntimicrobial ChemotherapyAntimicrobial PharmacokineticsDosing ConsiderationsAntimicrobial PharmacodynamicsMedicineClinical MicrobiologyNephrologyImpaired Renal FunctionPharmacodynamic Modeling